Quantcast
Last updated on April 16, 2014 at 21:24 EDT
UCSF Launches Groundbreaking Online Registry To Drive Brain

UCSF Launches Groundbreaking Online Registry To Drive Brain Disease Research

Laura Kurtzman, UC San Francisco Brain Health Registry Brings Promise of Faster, Better Clinical Trials, New Treatments A new online project led by researchers at UC San Francisco promises to dramatically cut the time and cost of conducting...

Latest drug discovery Stories

2014-04-16 16:13:04

New screening technique opens the door to unlimited opportunities, both in terms of chemistry and biology research Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the...

2014-04-16 09:48:04

Over 20 years after the fatal fialuridine trial, a study published this week in PLOS Medicine demonstrates that mice with humanized livers recapitulate the drug's toxicity. The work suggests that this mouse model should be added to the repertoire of tools used in preclinical screening of drugs for liver toxicity before they are given to human participants in clinical trials. A retrospective analysis by the US National Academy of Sciences of all preclinical fialuridine toxicity tests, which...

2014-04-15 08:30:06

Purchase adds global regulatory writing and submission services to Certara's drug development consulting expertise NEW YORK, April 15, 2014 /PRNewswire/ -- Arsenal Capital Partners, a leading New York based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Synchrogenix, the leading regulatory writing and related services firm. Synchrogenix provides services to pharmaceutical,...

2014-04-15 04:20:50

LONDON, April 15, 2014 /PRNewswire/ -- reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014. Professor Schinazi has had a long and prestigious career in the industry having founded several successful biotechnology companies including Pharmasset, where he chaired...

2014-04-14 23:06:18

MD Biosciences enters into an agreement with Janssen Research & Development, LLC to screen an extensive library of compounds with its proprietary Senerga® Phenotypic Screening Platform. Senerga®PSP is based on three matrices covering pathways related to inflammatory, metabolic, cardiovascular, and CNS diseases in addition to delivering preliminary toxicology data. St Paul, MN (PRWEB) April 14, 2014 MD Biosciences announces that it has entered into a research agreement with...

2014-04-14 12:35:36

DALLAS, April 14, 2014 /PRNewswire/ -- According to new market research report the "Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, Qpcr), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018" published by MarketsandMarkets, The global Cell Analysis Market was valued at an estimated $16.7 Billion in 2013 and is expected to reach $23.0...

2014-04-14 12:33:26

Johnson & Johnson Innovation Is First Collaborator LA JOLLA, Calif. and JUPITER, Fla., April 14, 2014 /PRNewswire-USNewswire/ -- The Scripps Research Institute (TSRI) today announced the formation of Scripps Advance, a new drug discovery initiative to translate early-stage biomedical research projects, both internal and external to TSRI, into clinical development candidates. Scripps Advance's first collaborator in this new endeavor is the Johnson & Johnson Innovation Center in...

2014-04-13 23:00:56

Metabolomics is one of the fastest growing markets in the scientific arena, finding its application in essential fields such as drug discovery, toxicology assessment, nutrigenomics and biomarker discovery. http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html (PRWEB) April 13, 2014 The report "Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and...

2014-04-10 23:23:30

Join ChanTest for their complimentary 2014 series of scientific meetings, where the company will bring together prominent scientific partners from pharmaceutical and biotech groups active in drug discovery. Cleveland, Ohio (PRWEB) April 10, 2014 Collaborative relationships between academia, the industry and vendors are one of the most important aspects of achieving innovation, efficiency and success in drug discovery. To that end, ChanTest will host a series of scientific symposia and...

2014-04-11 00:21:46

DUBLIN, April 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/7tctzp/nitric_oxide) has announced the addition of a new report "Nitric Oxide - Therapeutics, Markets and Companies" [http://www.researchandmarkets.com/research/7tctzp/nitric_oxide ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a...